Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This will be a prospective assessment of whether adjuvant Netarsudil use in patients
undergoing Descemetorhexis without endothelial keratoplasty improves time to corneal
clearance and post-operative central endothelial cell counts. The anticipated enrollment is
25 patients.